Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-Dong, Seoul, South Korea.
Am J Hematol. 2010 Oct;85(10):760-4. doi: 10.1002/ajh.21824.
Compared with the West, the overall incidence of lymphoid neoplasms is lower, and the subtype distribution is distinct in Asia. To comprehensively investigate the subtype distribution with the age and sex factors, and temporal changes of subtype proportions, we re-assessed all patients with lymphoid neoplasms diagnosed at a large oncology service in the Republic of Korea from 1989 to 2008 using the World Health Organization classifications. Of the total 5,318 patients, 66.9% had mature B-cell neoplasms, 12.5% had mature T/natural killer (NK)-cell neoplasms, 16.4% had precursor lymphoblastic leukemia/lymphoma (ALL/LBL), and 4.1% had Hodgkin's lymphoma. The most common subtypes were diffuse large B-cell lymphoma (30.5%), plasma cell myeloma (14.0%), extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma; 12.4%), B-cell ALL/LBL (11.3%), Hodgkin's lymphoma (4.1%), peripheral T-cell lymphoma unspecified (4.0%), T-cell ALL/LBL (3.9%), and extranodal NK/T-cell lymphoma of nasal type (3.9%). Most subtypes showed male predominance, with an average M/F ratio of 1.3. Most mature lymphoid neoplasms were diseases of adults (mean age, 53.5 yr), whereas ALL/LBLs were of young individuals (mean age, 20.3 yr). When the relative proportion of subtypes were compared between two decades (1989-1998 vs. 1999-2008), especially MALT lymphoma has increased in proportion, whereas T/NK-cell neoplasms and ALL/LBL have slightly decreased. In summary, the lymphoid neoplasms of Koreans shared some epidemiologic features similar to those of other countries, whereas some subtypes showed distinct features. Although the increase in incidence of lymphoid neoplasms is relatively modest in Korea, recent increase of MALT lymphoma and decrease of T/NK-cell neoplasms and ALL/LBL are interesting findings.
与西方相比,亚洲的淋巴肿瘤总体发病率较低,亚型分布也不同。为了全面研究年龄和性别因素以及亚型比例的时间变化与淋巴肿瘤的亚型分布,我们使用世界卫生组织的分类方法,重新评估了韩国一家大型肿瘤服务机构 1989 年至 2008 年期间诊断的所有淋巴肿瘤患者。在总共 5318 名患者中,66.9%为成熟 B 细胞肿瘤,12.5%为成熟 T/自然杀伤 (NK)-细胞肿瘤,16.4%为前体淋巴母细胞白血病/淋巴瘤 (ALL/LBL),4.1%为霍奇金淋巴瘤。最常见的亚型是弥漫性大 B 细胞淋巴瘤 (30.5%)、浆细胞瘤 (14.0%)、黏膜相关淋巴组织型结外边缘区淋巴瘤 (MALT 淋巴瘤;12.4%)、B 细胞 ALL/LBL (11.3%)、霍奇金淋巴瘤 (4.1%)、未特指的外周 T 细胞淋巴瘤 (4.0%)、T 细胞 ALL/LBL (3.9%)和鼻型结外 NK/T 细胞淋巴瘤 (3.9%)。大多数亚型为男性多见,平均男女比为 1.3。大多数成熟淋巴肿瘤是成人疾病 (平均年龄 53.5 岁),而 ALL/LBL 则是年轻人的疾病 (平均年龄 20.3 岁)。比较两个十年间 (1989-1998 年与 1999-2008 年) 的亚型相对比例时,特别是 MALT 淋巴瘤的比例有所增加,而 T/NK 细胞肿瘤和 ALL/LBL 则略有减少。总之,韩国的淋巴肿瘤具有一些与其他国家相似的流行病学特征,而一些亚型则具有明显的特征。尽管韩国淋巴肿瘤的发病率相对较低,但最近 MALT 淋巴瘤的增加和 T/NK 细胞肿瘤和 ALL/LBL 的减少是有趣的发现。